Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.

Wang KC, Lee CL, Chen SY, Chen JC, Yang CW, Chen SJ, Tsai CP.

J Interferon Cytokine Res. 2013 Feb;33(2):58-64. doi: 10.1089/jir.2012.0040.

PMID:
23398365
2.

Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica.

Farrokhi M, Rezaei A, Amani-Beni A, Etemadifar M, Kouchaki E, Zahedi A.

Acta Neurol Belg. 2015 Dec;115(4):609-14. doi: 10.1007/s13760-015-0491-3. Epub 2015 May 26.

PMID:
26008726
3.

Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.

Matsushita T, Tateishi T, Isobe N, Yonekawa T, Yamasaki R, Matsuse D, Murai H, Kira J.

PLoS One. 2013 Apr 18;8(4):e61835. doi: 10.1371/journal.pone.0061835. Print 2013.

4.

Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.

Wu A, Zhong X, Wang H, Xu W, Cheng C, Dai Y, Bao J, Qiu W, Lu Z, Hu X.

Can J Neurol Sci. 2012 Nov;39(6):813-20.

PMID:
23041403
5.

Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.

Shimizu Y, Ota K, Ikeguchi R, Kubo S, Kabasawa C, Uchiyama S.

J Neuroimmunol. 2013 Oct 15;263(1-2):148-51. doi: 10.1016/j.jneuroim.2013.07.005. Epub 2013 Jul 30.

PMID:
23910387
6.

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG.

Lancet. 2004 Dec 11-17;364(9451):2106-12.

PMID:
15589308
7.

Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica.

Yang T, Wang S, Zheng Q, Wang L, Li Q, Wei M, Du Z, Fan Y.

BMC Neurol. 2016 Jul 11;16:96. doi: 10.1186/s12883-016-0622-3.

8.

[Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital].

Vaknin-Dembinsky A, Levin N, Raz N, Abramsky O, Karussis D, Brill L, Petrou P, Ovadia H.

Harefuah. 2013 Feb;152(2):101-5, 122. Hebrew.

PMID:
23513502
9.

[Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].

Yang Y, Wu WP, Huang DH, Wu L.

Zhonghua Yi Xue Za Zhi. 2012 Nov 20;92(43):3032-5. Chinese.

PMID:
23328372
10.

Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica.

Wang KC, Tsai CP, Lee CL, Chen SY, Chin LT, Chen SJ.

Neuroscience. 2012 Dec 13;226:510-6. doi: 10.1016/j.neuroscience.2012.08.041.

PMID:
23122444
11.

The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis.

Storoni M, Petzold A, Plant GT.

PLoS One. 2011;6(8):e23489. doi: 10.1371/journal.pone.0023489. Epub 2011 Aug 18.

12.

Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.

Wang HH, Dai YQ, Qiu W, Lu ZQ, Peng FH, Wang YG, Bao J, Li Y, Hu XQ.

J Clin Neurosci. 2011 Oct;18(10):1313-7. doi: 10.1016/j.jocn.2011.01.031. Epub 2011 Jul 26.

PMID:
21795048
13.

Overlapping CNS inflammatory diseases: differentiating features of NMO and MS.

Juryńczyk M, Craner M, Palace J.

J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):20-5. doi: 10.1136/jnnp-2014-308984. Epub 2014 Sep 23. Review.

PMID:
25248365
14.

Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - a pilot study.

Michael BD, Elsone L, Griffiths MJ, Faragher B, Borrow R, Solomon T, Jacob A.

Cytokine. 2013 Oct;64(1):90-6. doi: 10.1016/j.cyto.2013.07.019. Epub 2013 Aug 12.

PMID:
23941778
15.

Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis.

Uzawa A, Mori M, Ito M, Uchida T, Hayakawa S, Masuda S, Kuwabara S.

J Neurol. 2009 Dec;256(12):2082-4. doi: 10.1007/s00415-009-5274-4.

PMID:
19655191
17.

Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.

Kira J.

J Neurol Sci. 2011 Dec 15;311(1-2):69-77. doi: 10.1016/j.jns.2011.08.043. Epub 2011 Sep 29. Review.

PMID:
21962794
18.

Serum analysis by 1H nuclear magnetic resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis.

Moussallieh FM, Elbayed K, Chanson JB, Rudolf G, Piotto M, De Seze J, Namer IJ.

Mult Scler. 2014 Apr;20(5):558-65. doi: 10.1177/1352458513504638. Epub 2013 Sep 30.

PMID:
24080986
19.

[Devic's neuromyelitis optica: diagnosis after 10 years of bilateral severe relapsing optic neuritis].

Déral-Stéphant V, Roux-Lelièvre C, Vignal R, Stéphant E, Faivre A, Alla P.

J Fr Ophtalmol. 2008 Sep;31(7):705-9. French.

20.

Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.

Mouzaki A, Rodi M, Dimisianos N, Emmanuil A, Kalavrizioti D, Lagoudaki R, Grigoriadis NC, Papathanasopoulos P.

PLoS One. 2015 Aug 28;10(8):e0135434. doi: 10.1371/journal.pone.0135434. eCollection 2015. Erratum in: PLoS One. 2016;11(3):e0151411.

Supplemental Content

Support Center